Skip to main content

Advertisement

Table 5 Clinical validity EORTC QLQ-C30 and QLQ-BR23 Amharic version in women with breast cancer in Ethiopia (n = 146)

From: Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia

Quality of life score: mean(SD)
 EORTC-QLQ-C30BaselineEnd of 1st CTb cyclep-value
Overall QoLGlobal Health status57.36(20.09)41.72(19.24)0.000
Physical68.63(26.06)51.00(23.70)0.000
Role52.74(38.85)23.74(31.37)0.000
Functional scalesEmotional80.02(22.60)67.81(25.14)0.000
Cognitive86.41(19.96)77.39(26.31)0.000
Social74.88(30.59)58.22(33.11)0.000
Fatigue28.69(30.40)72.07(26.10)0.000
Symptoms scalesNausea and Vomiting3.31(11.84)53.53(34.19)0.000
Pain32.53(30.53)42.00(33.11)0.001
Dyspnea19.40(29.75)28.76(29.97)0.003
Insomnia27.85(34.58)35.61(37.88)0.024
Single itemsAppetite loss17.80(29.59)71.23(31.22)0.000
Constipation10.27(21.99)22.83(31.74)0.000
Diarrhea2.74(12.07)16.89(30.38)0.000
Financial problem61.18(36.72)65.52(33.77)0.000
EORTC-QLQ-BR23
 Functional scalesBody Image72.54(42.45)72.60(27.24)0.985
Sexual Functioning21.11(36.95)12.21(28.72)0.004
Therapya side effects12.88(15.08)50.71(19.70)0.000
 Symptoms scaleBreast symptoms22.48(22.34)17.63(19.94)0.000
Arm symptoms26.03(26.08)18.79(23.18)0.000
 Single itemsFuture perspectives69.63(33.43)63.69(35.21)0.041
Sexual Enjoyment72.91(32.70)70.83(34.15)0.817
  1. aSystemic therapy side effects
  2. bAfter three weeks, on 21st day of the CT (Chemotherapy) or on the first day of 2nd cycle CT.
  3. SD Standard Deviation, QoL Quality of Life